what are the different types of glp 1 drugs List GLP-1 Receptor Agonists for Diabetes & Weight Loss GLP-1 rec agonists have evolved

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking behaviors through central reward and dopamine-related pathways

Eli Lilly and Company has announced Zepbound (tirzepatide) 2.5mg and 5mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand

Novo Nordisk is seeking to replace the existing glucagon-like peptide-1 (GLP-1) receptor agonist (RA) with a second-generation drug, semaglutide, to fight diabetes and obesity in Korea.On Thursday, the Ministry of Food and Drug Safety authorized the use of Novo Nordisks Ozempic to treat adults with

Should Medicare and Medicaid expand to cover weight loss drugs

If the discoveries that gave us Ozempic and Mounjaro find their way to the Nobel spotlight, who would win